Avanos Medical Inc (AVNS)
Receivables turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 687,800 | 681,500 | 682,400 | 680,100 | 705,700 | 749,900 | 780,700 | 814,300 | 820,000 | 795,900 | 777,900 | 761,300 | 744,600 | 736,200 | 737,800 | 715,100 | 714,800 | 719,600 | 705,300 | 713,800 |
| Receivables | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
Receivables turnover = Revenue (ttm) ÷ Receivables
= $687,800K ÷ $—K
= —
The receivables turnover ratio of Avanos Medical Inc for the period from March 31, 2020, to December 31, 2024, is not available as indicated by the data provided. The absence of specific values for receivables turnover in the financial statements suggests that detailed information on the company's accounts receivables and their turnover efficiency is not provided in the current dataset. The receivables turnover ratio is a key financial metric that indicates how efficiently a company is managing its accounts receivable, collecting outstanding amounts from customers, and converting credit sales into cash.
Without the receivables turnover values, it is challenging to evaluate the effectiveness of Avanos Medical Inc in managing its accounts receivable over time. A high receivables turnover ratio typically implies that a company is efficient in collecting payments from customers, while a low ratio may indicate potential issues with credit and collection policies. Monitoring changes in the receivables turnover ratio over time can provide valuable insights into the company's liquidity, credit risk, and overall financial performance.
Peer comparison
Dec 31, 2024